AdaptHealth (AHCO) Depreciation & Amortization (CF) (2019 - 2026)

AdaptHealth's Depreciation & Amortization (CF) history runs 8 years deep, the most recent figure standing at $106.5 million for Q1 2026.

• On a quarterly basis, Depreciation & Amortization (CF) rose 12.85% year-over-year to $106.5 million in Q1 2026; TTM through Mar 2026 was $394.1 million, a 7.43% increase from a year earlier, with the FY2025 full-year figure at $381.9 million, up 4.54% from the prior year.
• Depreciation & Amortization (CF) rose to $106.5 million in Q1 2026 per AHCO's latest filing, from $97.5 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $106.5 million in Q1 2026 and bottomed at $77.0 million in Q1 2022.
• The 5-year median for Depreciation & Amortization (CF) is $92.9 million (2024), against an average of $93.4 million.
• Across the five-year window, Depreciation & Amortization (CF) soared 63.18% in 2022 and dropped 9.75% in 2023, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $102.3 million in 2022, then declined by 9.75% to $92.4 million in 2023, then dropped by 1.98% to $90.5 million in 2024, then rose by 7.7% to $97.5 million in 2025, then increased by 9.19% to $106.5 million in 2026.
• Per Business Quant, the three latest AHCO Depreciation & Amortization (CF) figures stand at $106.5 million (Q1 2026), $97.5 million (Q4 2025), and $97.7 million (Q3 2025).